By Route of Administration

Saliva / Buccal Swab (At-Home) Market Analysis

Cross-industry research covering Saliva / Buccal Swab (At-Home) across 1 market reportspanning Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics.

1 Reports

1 Industries

Reports Covering Saliva / Buccal Swab (At-Home)

Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics·Market: USD 2.7 Billion (2025)·CAGR: 7.2%

Saliva-based kits dominate consumer genomics due to their non-invasive nature and ambient-temperature shipping compatibility. The format is the direct enabler of pure DTC distribution without phlebotomy infrastructure.

68%

Market Share

6.8%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments